Louise Pettersson
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks
- Contribution to journal › Article
-
Mark
Factors affecting hospitalization and mortality in a retrospective study of elderly patients with heart failure
- Contribution to journal › Article
- 2021
-
Mark
Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
- Contribution to journal › Article
-
Mark
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
(2021) In International Journal of Laboratory Hematology
- Contribution to journal › Article
-
Mark
Measurable residual disease and clonal evolution in acute myeloid leukemia with focus on NPM1-mutations
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis
- Contribution to journal › Article
- 2019
-
Mark
Measurable residual disease testing for personalized treatment of acute myeloid leukemia
- Contribution to journal › Scientific review
- 2018
-
Mark
Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow
- Contribution to journal › Letter
- 2017
-
Mark
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
- Contribution to journal › Article
- 2016
-
Mark
Improved minimal residual disease detection by targeted quantitative polymerase chain reaction in Nucleophosmin 1 type a mutated acute myeloid leukemia
- Contribution to journal › Article
